– Main Menu –
- - Coalition Building
- - Information and Analysis
- - Policy Leadership
- Commercial Coalition Members
- Abuse-Deterrent Medications
- Access to Quality Care
- - Addiction Treatment
- - Pain Care
- - Testing for Substance Use
- Counterfeit & Gray Market Drugs
- Prescriber Education
- Prescription Monitoring Programs
Join Our Coalition
- CLAAD in the News
- - CLAAD Opinion
- - Third Party Opinion
- News Releases
- Partner Headlines
- State and National News
- External Resources
- National Strategy
- Policy Activity
- Prescription Drug Abuse Statistics
Information and Analysis
Commercial Coalition Members
Access to Quality Care
Testing for Substance Use
Counterfeit & Gray Market Drugs
Prescription Monitoring Programs
Join Our Coalition
CLAAD in the News
Third Party Opinion
State and National News
Prescription Drug Abuse Statistics
Happy to see more coverage of
, but we join
in asking where are quotes from pain patients:
15 hours ago
OK moves one step closer to requiring physicians to check a database before prescribing controlled substances:
18 hours ago
In VT, opiate abuse has increased but the number of overdose deaths has not risen:
19 hours ago
Nearly 1 million veterans are treated with opioids, but more than half continue taking opioids chronically study says
20 hours ago
Indiana NAS bill summary:
Appears to be a health-focused effort w/o law enforcement involvement. -mb
21 hours ago
CLAAD in the News
FDA Responds to CLAAD Citizen Petition
In June 2013, CLAAD requested that the FDA implement a policy requiring new oral opioid medications to have safety features designed to deter common forms of manipulation for purposes of abuse,...
25 Oct 2013
Feds Must Ensure Prescription Drug ‘Gatekeepers’ Get Proper Education
An article from the newest issue of University of Maryland Journal of Health Care Law & Policy recommends mandatory prescriber education at the federal level to prevent the abuse of...
20 Aug 2013
The Locking Cap To Be Distributed Nationwide
A major U.S. drug distributor recently agreed to distribute The Locking Cap nationwide. The Locking Cap is a prescription bottle cap with a combination lock. It is designed to keep children from...
19 Jul 2013
Opioid Abuse Epidemic Spurs Search For Safer Medications
In an article for Bloomberg.com, CLAAD Executive Director Michael Barnes explains the need for prompt FDA action to protect patients and ensure the future of abuse-deterrent medications. CLAAD...
02 Jul 2013
WFAN New York – CLAAD Petitions FDA To Implement Obama Admin. Policy
Host Bob Salter and CLAAD Executive Director Michael Barnes discuss on WFAN-FM in New York CLAAD’s recent Citizen Petition urging the FDA to take two vital actions to reduce prescription drug...
30 Jun 2013
Federal Scrutiny of Patent Settlements — Will It Slow Innovation?
In a television interview on Washington D.C.’s Fox5 morning news program, CLAAD’s executive director explained the Supreme Court decision allowing the Federal Trade Commission to...
20 Jun 2013
Groups Join To Petition FDA on Opioids
The National Association of Drug Diversion Investigators, National Family Partnership, and Ryan’s Cause joined CLAAD to submit a Citizen Petition to the U.S. Food and Drug Administration (FDA)....
18 Jun 2013
CLAAD Policy Activity
CLAAD Policy Statement on Testing for Substance Use
Posted on 06 Mar 2014
CLAAD Presentation at West Virginia Law Review Symposium
Posted on 13 Feb 2014
CLAAD Objects to Wasteful Medicare Policy on Testing for Substance Use
Posted on 07 Feb 2014
chronic pain management
drug use during pregnancy
neonatal abstinence syndrome
prescription drug abuse
prescription drug disposal
prescription drug fraud
prescription monitoring programs
substance use disorders
Information presented on this site is for educational purposes and should not be relied upon as legal advice.
For information on specific policy issues, legal matters, or factual circumstances, please seek legal counsel.
Copyright © CLAAD 2013. All rights reserved.